Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

RAPT Therapeutics Inc (RAPT)

  • SEC News
  • Jan. 20, 2026, 11:11 UTC
  • 1
  • 1 comments

(61% Neutral) RAPT Therapeutics Inc (RAPT) Announces Business Combination

Comment Full text

Adlai Nortye Ltd (ANL)

  • SEC News
  • Jan. 20, 2026, 11:10 UTC
  • 5
  • 0 comments

New Form SCHEDULE 13G - Adlai Nortye Ltd. Filed: 2026-01-20 AccNo: 0000950103-26-000641 Size: 15 KB

Comment Full text

Aethlon Medical Inc (AEMD)

  • SEC News
  • Jan. 20, 2026, 11:04 UTC
  • 4
  • 0 comments

New Form EFFECT - AETHLON MEDICAL INC Filed: 2026-01-16 AccNo: 9999999995-26-000202 Size: 1 KB

Comment Full text

Tharimmune Inc (THAR)

  • SEC News
  • Jan. 20, 2026, 11:04 UTC
  • 4
  • 0 comments

New Form EFFECT - Tharimmune, Inc. Filed: 2026-01-16 AccNo: 9999999995-26-000208 Size: 1 KB

Comment Full text

Scworx Corp (WORX)

  • SEC News
  • Jan. 20, 2026, 11:04 UTC
  • 4
  • 0 comments

New Form EFFECT - SCWorx Corp. Filed: 2026-01-16 AccNo: 9999999995-26-000204 Size: 1 KB

Comment Full text

Collplant Biotechnologies Ltd (CLGN)

  • SEC News
  • Jan. 20, 2026, 11:04 UTC
  • 4
  • 0 comments

New Form EFFECT - CollPlant Biotechnologies Ltd Filed: 2026-01-16 AccNo: 9999999995-26-000206 Size: 2 KB

Comment Full text

Allurion Technologies Inc (ALUR)

  • SEC News
  • Jan. 20, 2026, 11:04 UTC
  • 4
  • 0 comments

New Form EFFECT - ALLURION TECHNOLOGIES, INC. Filed: 2026-01-16 AccNo: 9999999995-26-000210 Size: 1 KB

Comment Full text

Avadel Pharmaceuticals (AVDL)

  • SEC News
  • Jan. 20, 2026, 11:02 UTC
  • 1
  • 1 comments

(99% Neutral) Avadel Pharmaceuticals (AVDL) Announces Business Combination

Comment Full text

IX Biopharma LTD. (42C)

  • SEC News
  • Jan. 20, 2026, 10:36 UTC
  • 4
  • 0 comments

General Announcement: Press Release - iX Biopharma Named Among Singapores Fastest Growing Companies 2026

Comment Full text

Top Glove Corporation BHD (BVA)

  • SEC News
  • Jan. 20, 2026, 10:30 UTC
  • 4
  • 0 comments

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

Comment Full text
  • Previous
  • 114
  • 115
  • 116
  • 117
  • 118
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189146)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124505)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin